search
pharmaceuticals
Illustrative image of a research lab. (Motortion; iStock by Getty Images)
Pharmaceutical firm 89bio files for $70 million IPO
By Luke Tress
Herzliya- and San Francisco-based company with ties to medical giant Teva developing drug to treat NASH, a severe liver disease
Illustrative image of a research lab. (Motortion; iStock by Getty Images)
October 16, 2019, 11:22 am
Pharmaceutical firm 89bio files for $70 million IPO
Herzliya- and San Francisco-based company with ties to medical giant Teva developing drug to treat NASH, a severe liver disease
By Luke Tress
Dr. Guido Fanelli (right) entering police headquarters in Parma, Italy, for questioning in an alleged pharmaceutical kickback scheme, May 8, 2017. (AP/Marco Vasini)
May 29, 2019, 10:09 am
Purdue Pharma’s ‘Pain League’ allegedly pushed opioids in Italy
Drug company used Italian doctor, apparently employing practices that helped create US addiction crisis that has claimed 400,000 lives
By CLAIRE GALOFARO and Frances D'Emilio
An illustrative photo of a patient receiving an injection. (photo credit: Miriam Alster/Flash90/File)
April 11, 2018, 12:19 am
Mylan buys rights to Israel-developed Multiple Sclerosis treatment
MS drug developed by Mapi Pharma requires a once-monthly injection instead of 3 times a week
By TOI staff
Kåre Schultz, CEO and president of Teva. (Courtesy)
February 8, 2018, 9:17 pm
Teva chief reports ‘strong progress’ in restructuring plan
CEO Kåre Schultz says company headquarters will remain in Israel despite shake-up that will slash a quarter of local workforce
By Josef Federman
Some Ashkenazi Jewish women who carry a particular BRCA-1 genetic mutation have a 65 percent chance of developing breast cancer. (Media for Medical/UIG via Getty Images)
January 14, 2018, 4:28 pm
US okays 1st drug to fight ‘Jewish’ breast cancer gene
Lynparza approved by FDA for patients with the inherited BRCA mutations who have undergone chemotherapy
By AP and TOI staff
Mitsubishi Tanabe headquarters in Osaka, Japan. (screen capture: Google Street View)
July 24, 2017, 3:25 pm
Israeli drug maker NeuroDerm sold to Japanese pharma giant for $1.1b
Sale to Mitsubishi Tanabe is largest-ever of Israeli healthcare company; firm developing delivery methods for meds that fight Parkinson’s symptoms
By TOI staff
A general view of TEVA Pharmaceutical Industries in Jerusalem, Israel, October 11, 2013. (Yonatan Sindel/Flash90)
June 11, 2017, 5:53 pm
Teva shares rise in Tel Aviv as migraine results buoy investors
Drug is expected to lessen headache for pharma firm, which is facing stiff competition for its flagship anti-MS treatment Copaxone
By Shoshanna Solomon
The red hill seen from Kibbutz Givat Brenner that inspired the name of biotech company RedHill (Courtesy)
April 13, 2017, 12:29 pm
Kibbutz duo-turned-entrepreneurs on quest to whip gut bugs
Israeli biotech firm RedHill is conducting late-stage clinical trials to tackle Crohn’s disease and the ulcer-generating H. pylori bacteria
By Shoshanna Solomon
The Jerusalem office of the Israeli drug company Teva Pharmaceuticals (Yonatan Sindel/Flash90)
August 3, 2016, 8:21 am
Teva completes $40b purchase of Allergan generics arm
CEO of Israeli drugs giant says deal, which puts it among top 10 global pharmaceutical firms, won’t push up medicine prices
By Joe Dyke
A Frutarom R&D lab in Germany (Courtesy)
May 4, 2016, 12:12 pm
Frutarom makes fifth acquisition of 2016
With 17 new acquisitions in the past 17 months, the world’s seventh-biggest flavorings firm is aiming for $2 billion in annual sales by 2020
By TOI staff
Members of Italy's biotech delegation at May's IATA event in Tel Aviv (Limor Edry)
August 10, 2015, 4:54 pm
Israeli biotech firms to seek deals in Italy
Dozens of life science companies from Israel will attend a special event in Milan next month
By David Shamah
The Jerusalem office of the Israeli drug company Teva Pharmaceuticals (Yonatan Sindel/Flash90)
July 27, 2015, 1:17 pm
Israel’s Teva buys part of Allergan drug company for $40.5 billion
In largest deal in country’s history, pharmaceutical giant acquires Dublin-based firm’s generic drug business, mostly for cash
By AFP, AP and TOI staff
July 23, 2015, 5:32 pm
Mylan foundation to block Teva pharma’s hostile takeover bid
Independent group warns Israeli giant’s purchase of the US drug company will reduce competition, increase prices
By AFP
Qlight was awarded the Chief Scientist's prize for nanotechnology at the Israel Nanotech event in March 27 2014. (L to R) Chief Scientist of the Ministry of Economy of the State of Israel, Dr. Avi Hasson, Qlight Nanotech's VP R&D, Professor Uri Banin, Qlight Nanotech's founder and CTO, Yaacov Michlin, CEO of Yissum and Chairman of the Board of Qlight Nanotech, and Dr. Volker Hilarius, Director International Projects at Merck. (Courtesy)
June 30, 2015, 4:58 pm
Merck CEO sees firm’s future intertwined with Israel’s
15% of pharma firm Merck KgaA’s products have Israeli roots, and now an Israeli start-up will help the firm grow in new directions
By David Shamah
A Microchips Biotech chip (Courtesy)
June 24, 2015, 5:07 pm
With microchip implant, doctors can administer meds remotely
Israeli pharmaceutical giant Teva is teaming up with a US tech firm in the first-ever deal to use biochips to deliver pharmaceutical dosages
By David Shamah
Load More